Welcome to our dedicated page for QUAKER CHEMICAL SEC filings (Ticker: KWR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on QUAKER CHEMICAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into QUAKER CHEMICAL's regulatory disclosures and financial reporting.
Quaker Chemical Corp executive Jeewat Bijlani, EVP, Global Specialties & Chief Growth Officer, reported an "other" disposition of 7 shares of Common Stock on August 7, 2026. Footnotes state these shares had been escrowed to secure sellers' indemnification obligations from the acquisition of Global Houghton Ltd. and were forfeited upon resolution of remaining indemnification claims and release of the escrow. The reported price of $153.20 per share is a volume-weighted average used for escrow calculations. After this event, Bijlani held 6,741 shares directly and 62 shares indirectly via a 401(k) plan, with the plan balance based on a statement as of June 30, 2026.
Quaker Chemical Corp director William H. Osborne reported a sale of 600 shares of common stock on August 4, 2026, in an open market or private transaction at $168.31 per share, leaving 616 shares held directly. He also reports 6,285 shares held indirectly through the Revocable Trust Agreement of William H. Osborne, Jr. U/A/D 12/30/2004.
Quaker Chemical Corporation (Quaker Houghton) has filed a Form S-3 shelf registration to permit the resale of up to 3,640,129 shares of common stock by a single selling security holder, Gulf Hungary Holding Korlátolt Felelősségű Társaság. Of these shares, 5,017 are currently held in escrow.
The company is not selling any shares in this offering and will not receive any proceeds from resales by the selling holder. The registered shares stem from stock issued as part of Quaker’s 2019 acquisition of Houghton International. As of July 30, 2026, 17,207,702 common shares were outstanding, and the selling holder’s stake represents 21.0% of the voting power before any sales.
The prospectus highlights that potential sales, or expectations of sales, of this sizable block could create “market overhang” and contribute to stock-price volatility, and it summarizes Pennsylvania anti-takeover provisions, board classification, and other charter and by-law features that could delay or discourage a change in control.
Quaker Chemical Corporation (Quaker Houghton) has filed a resale shelf registration on Form S-3 covering up to 2,085 shares of common stock for a selling security holder. These shares, including 9 currently held in escrow, were issued as part of the 2019 Houghton combination consideration.
The selling security holder, executive vice president and chief growth officer Jeewat Bijlani, may sell the registered shares from time to time using various methods described under the plan of distribution. The company will not receive any proceeds from these sales.
As context, 17,207,702 shares of common stock were issued and outstanding as of July 30, 2026; this is a baseline figure, not the amount being offered. The stock trades on the New York Stock Exchange under the symbol “KWR.”
Quaker Chemical Corporation delivered improved results for the quarter ended June 30, 2026. Net sales were $532.6 million, up 10% from a year earlier, driven by roughly 7% higher volumes, 2% favorable currency and 1% price/mix. Net income was $26.8 million versus a prior-year loss of $66.6 million, with diluted EPS of $1.55.
Excluding non-recurring and non-core items, non-GAAP net income was $37.9 million ($2.19 per diluted share), and adjusted EBITDA was $85.2 million, up from $75.5 million. All three segments grew sales; EMEA and Asia/Pacific increased operating earnings on better margins, while Americas earnings declined on lower margins and higher SG&A despite higher revenue.
Operating cash flow for the first half of 2026 was $33.2 million, as higher earnings were offset by working-capital outflows from higher receivables and inventory builds amid supply-chain risks. The company ended the quarter with $155.1 million of cash and $876.1 million of debt and remained in compliance with its Amended Credit Facility covenants.
Management continued multi-year restructuring, including a 2026 global transformation program and the 2022 cost and optimization program, together reducing headcount by about 540 positions and leaving $8.8 million accrued. An immaterial cash-flow presentation error in revolving credit activity was identified and will be revised in future comparative periods.
Quaker Houghton reported strong second-quarter 2026 results, with net sales of $532.6 million, up 10% year over year, driven by 7% higher volumes, 2% favorable foreign exchange and 1% price/mix. The company generated net income of $26.8 million, or $1.55 diluted EPS, versus a net loss of $66.6 million, or $(3.78) per share, a year earlier. On a non-GAAP basis, net income was $37.9 million and non-GAAP diluted EPS $2.19, a 28% increase. Adjusted EBITDA rose to $85.2 million, up about 13%, with a 16.0% margin.
All regions contributed to growth: Americas sales rose 7%, EMEA 13%, and Asia/Pacific 12%, with segment operating earnings higher in EMEA and Asia/Pacific. For the six months, operating cash flow was $33.2 million. As of June 30, 2026, the company had $876.1 million of gross debt, cash of $155.1 million, and net debt of approximately $721.0 million, equating to a 2.3x net debt to trailing twelve months adjusted EBITDA leverage ratio. Quaker Houghton increased its quarterly dividend by about 4.3%, repurchased 170,568 shares for $24.2 million, and authorized a new $250 million share repurchase program. Management expects stable demand with flat to slightly positive end markets and targets gross margins within its desired range, supporting meaningful revenue and adjusted EBITDA growth over 2026.
Quaker Chemical Corporation reports a leadership change in its finance organization. On June 30, 2026, Steven Dassing resigned as Vice President, Corporate Controller and Principal Accounting Officer, effective July 22, 2026, to pursue another career opportunity, and the company states the resignation does not stem from any dispute or disagreement.
After his resignation becomes effective, Executive Vice President and Chief Financial Officer Mr. Coler, age 53, will also serve as Principal Accounting Officer. The company notes there are no new compensatory arrangements for him in this added role and no family relationships or related-party transactions requiring disclosure.
Quaker Chemical EVP and CFO Thomas Coler reported routine equity compensation activity. On June 15, 2026, time-based restricted stock units and related dividend equivalent rights vested and converted into a total of 2,420 shares of common stock. In connection with this vesting, 741 shares were surrendered to cover withholding taxes, a non-market disposition that does not represent an open-market sale. The transactions reflect compensation vesting and derivative exercises rather than discretionary buying or selling.
Quaker Chemical director Lucrece Foufopoulos - De Ridder reported routine equity compensation and related tax withholding. On June 1, 2026, the director received 413 shares of common stock at $145.24 per share, reflecting 75% of the annual retainer paid in shares under the 2023 Director Stock Ownership Plan. On the same date, 124 shares were surrendered to cover statutory withholding taxes tied to these shares. After these transactions, the director directly owned 2,570 shares of Quaker Chemical common stock.
Quaker Chemical director Lucrece Foufopoulos - De Ridder reported routine equity compensation and related share movements. On June 1, 2026, she received a grant of 975 restricted stock units (RSUs) as part of 2026 compensation for non-management directors, which vest 100% on May 31, 2027 and accrue dividend equivalent rights.
On May 31, 2026, earlier time-based RSUs granted on June 1, 2025 fully vested, converting into 1,198 shares of common stock, and 18 dividend equivalent rights were settled into an equal number of shares. To cover statutory taxes on this vesting, 365 shares of common stock were surrendered, leaving her with 2,281 common shares held directly after these transactions.